Решетняк Татьяна Магомедалиевна
Russian Medical Academy of Continuous Professional Education · 86 works · 93 citations · h-index 5
Top works
- [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
- [Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up].
- [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
- [Antibodies to phospholipids and ischemic disorders of cerebral circulation in young age].
- Antiphospholipid syndrome: diagnosis, development, therapy.
- [Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases].
- [Antiphospholipid antibodies in Behcet's disease].
- [Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome].
- [Arterial hypertension and the antiphospholipid syndrome].
- [Antiphospholipid syndrome: serological markers, diagnostic criteria, clinical manifestations, classification, prognosis].
- [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
- [Antibodies to low density oxidated lipoprotein and ischemic cerebrovascular disorders in young patients].
- [Sneddon's syndrome and the primary antiphospholipid syndrome].
- [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
- [Warfarin in the treatment of antiphospholipid syndrome].
- [Sneddon's syndrome and systemic lupus erythematosus with cerebrovascular disturbances and widespread livedo].
- [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
- [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
- [Antiphospholipid syndrome and exogenic risk factors in thromboses].
- [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].